fbpx

CooperVision MiSight® 1 Day Contact Lens Now Available in Canada

The CooperVision MiSight® 1 day contact lens is now available for fitting by Eye Care Professionals. It is the world’s first one-day soft contact lens clinically proven to substantially slow the progression of myopia in children.

“In the short term, myopia robs children of their ability to fully participate in everyday life,” said Alexandra Donkin, Country Manager, CooperVision Canada. “Correcting it is only part of the battle, since the condition can worsen as a child matures. The MiSight® 1 day contact lens has been specifically developed to control that progression, which can significantly reduce the risk of myopia-related complications and vision loss later in life.”

For Eye Care Professionals, MiSight® 1 day is as easy to fit as a single-vision soft contact lens. They benefit from repeatable outcomes with minimal chair time and follow-up visits, compared to therapies such as OrthoK.

The lens was also designed for children’s ease of use and parental peace of mind. In a multi-centre study, 100 percent of children who had never worn contact lenses before found MiSight® 1 day easy to remove after one month of wear. After a single month of wear, 85 percent of children said the lenses were easy to insert4. Children were found to have not changed their daily activities, and their wearing experiences were similar to those of children wearing a single-vision lens.

Click HERE to read more.

 

Featured Posts

Nikon Optical Canada logo

Nikon Optical Canada Launches New Sun Lens Offer Including New Tint Colors for Stylish Protection

Nikon Optical Canada launches its new sun lens collection, including trendy SunStyle tints, polarized lenses, and SeeSun Mirror options—available in a wide range of Nikon designs starting April 15, 2025.

Read more
CooperVision

CooperVision Surpasses $5 Million in Cumulative Fundraising for OGS’s  World Sight Day Challenge

CooperVision announced that through the commitment and generosity of its employees around the world, the company has cumulatively raised more than $5 million for the Optometry Giving Sight (OGS) World Sight Day Challenge.

Read more
Empower your Practice With Data

EMPOWER Your Practice Series Launches with Strong Attendance and Practical Insights

Eye Care Business Canada, in collaboration with the Clinical & Refractive Optometry (CRO) Journal, officially launched its three-part CE series EMPOWER Your Practice on April 9 with the first webinar, The Digital Journey: Using Data to Drive Practice Growth & Patient Care.

Read more
EssilorLuxottica Oliver Peoples 2025 logo

EssilorLuxottica and Roger Federer Extend Exclusive Global Eyewear Collaboration Between the RF Brand and Oliver Peoples

EssilorLuxottica and Roger Federer announce the renewal of their successful collaboration for the design, manufacture and worldwide distribution of eyewear under the Roger Federer (“RF”) and Oliver Peoples brands.

Read more
Fighting Blindness Canada research

Gene Editing Therapy to be Tested for Treatment of Wet AMD

A phase 1 clinical trial will be launching soon to test a gene editing approach for wet age-related macular degeneration (wet AMD).

Read more
Nikon Optical Canada logo

Nikon Optical Canada Launches New Sun Lens Offer Including New Tint Colors for Stylish Protection

Nikon Optical Canada launches its new sun lens collection, including trendy SunStyle tints, polarized lenses, and SeeSun Mirror options—available in a wide range of Nikon designs starting April 15, 2025.

Read more
CooperVision

CooperVision Surpasses $5 Million in Cumulative Fundraising for OGS’s  World Sight Day Challenge

CooperVision announced that through the commitment and generosity of its employees around the world, the company has cumulatively raised more than $5 million for the Optometry Giving Sight (OGS) World Sight Day Challenge.

Read more
Empower your Practice With Data

EMPOWER Your Practice Series Launches with Strong Attendance and Practical Insights

Eye Care Business Canada, in collaboration with the Clinical & Refractive Optometry (CRO) Journal, officially launched its three-part CE series EMPOWER Your Practice on April 9 with the first webinar, The Digital Journey: Using Data to Drive Practice Growth & Patient Care.

Read more
EssilorLuxottica Oliver Peoples 2025 logo

EssilorLuxottica and Roger Federer Extend Exclusive Global Eyewear Collaboration Between the RF Brand and Oliver Peoples

EssilorLuxottica and Roger Federer announce the renewal of their successful collaboration for the design, manufacture and worldwide distribution of eyewear under the Roger Federer (“RF”) and Oliver Peoples brands.

Read more
Fighting Blindness Canada research

Gene Editing Therapy to be Tested for Treatment of Wet AMD

A phase 1 clinical trial will be launching soon to test a gene editing approach for wet age-related macular degeneration (wet AMD).

Read more
Nikon Optical Canada logo

Nikon Optical Canada Launches New Sun Lens Offer Including New Tint Colors for Stylish Protection

Nikon Optical Canada launches its new sun lens collection, including trendy SunStyle tints, polarized lenses, and SeeSun Mirror options—available in a wide range of Nikon designs starting April 15, 2025.

Read more
CooperVision

CooperVision Surpasses $5 Million in Cumulative Fundraising for OGS’s  World Sight Day Challenge

CooperVision announced that through the commitment and generosity of its employees around the world, the company has cumulatively raised more than $5 million for the Optometry Giving Sight (OGS) World Sight Day Challenge.

Read more
Empower your Practice With Data

EMPOWER Your Practice Series Launches with Strong Attendance and Practical Insights

Eye Care Business Canada, in collaboration with the Clinical & Refractive Optometry (CRO) Journal, officially launched its three-part CE series EMPOWER Your Practice on April 9 with the first webinar, The Digital Journey: Using Data to Drive Practice Growth & Patient Care.

Read more
EssilorLuxottica Oliver Peoples 2025 logo

EssilorLuxottica and Roger Federer Extend Exclusive Global Eyewear Collaboration Between the RF Brand and Oliver Peoples

EssilorLuxottica and Roger Federer announce the renewal of their successful collaboration for the design, manufacture and worldwide distribution of eyewear under the Roger Federer (“RF”) and Oliver Peoples brands.

Read more
Fighting Blindness Canada research

Gene Editing Therapy to be Tested for Treatment of Wet AMD

A phase 1 clinical trial will be launching soon to test a gene editing approach for wet age-related macular degeneration (wet AMD).

Read more
Nikon Optical Canada logo

Nikon Optical Canada Launches New Sun Lens Offer Including New Tint Colors for Stylish Protection

Nikon Optical Canada launches its new sun lens collection, including trendy SunStyle tints, polarized lenses, and SeeSun Mirror options—available in a wide range of Nikon designs starting April 15, 2025.

Read more
CooperVision

CooperVision Surpasses $5 Million in Cumulative Fundraising for OGS’s  World Sight Day Challenge

CooperVision announced that through the commitment and generosity of its employees around the world, the company has cumulatively raised more than $5 million for the Optometry Giving Sight (OGS) World Sight Day Challenge.

Read more
Empower your Practice With Data

EMPOWER Your Practice Series Launches with Strong Attendance and Practical Insights

Eye Care Business Canada, in collaboration with the Clinical & Refractive Optometry (CRO) Journal, officially launched its three-part CE series EMPOWER Your Practice on April 9 with the first webinar, The Digital Journey: Using Data to Drive Practice Growth & Patient Care.

Read more
EssilorLuxottica Oliver Peoples 2025 logo

EssilorLuxottica and Roger Federer Extend Exclusive Global Eyewear Collaboration Between the RF Brand and Oliver Peoples

EssilorLuxottica and Roger Federer announce the renewal of their successful collaboration for the design, manufacture and worldwide distribution of eyewear under the Roger Federer (“RF”) and Oliver Peoples brands.

Read more
Fighting Blindness Canada research

Gene Editing Therapy to be Tested for Treatment of Wet AMD

A phase 1 clinical trial will be launching soon to test a gene editing approach for wet age-related macular degeneration (wet AMD).

Read more